Hypoxanthine-guanine phosphoribosyltransferase. Characterization of a mutant in a patient with gout.
Irving H. Fox(Takeda (United States)), V Wyhofsky, Sachiko Omura, Michael Moore(Willamette University), Pamela J. Marchant, Issac Dwosh(University of Michigan), Sheila Lacroix
Cited by 38
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
|Gastroenterology|2014|714
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin
|New England Journal of Medicine|2005|694